We previously described two human DnaJ proteins, hTid-1 L and hTid-1 S , which are derived from alternative splicing of the TID1 gene, the human homologue of the Drosophila tumor suppressor lethal(2) tumorous imaginal discs, and showed that hTid-1 L promoted while hTid-1 S antagonized apoptosis. There are two subsets of helper T cells, Th1 and Th2, of which Th2 cells are significantly less prone to apoptosis induced by stimulation through the T-cell receptor. This apoptotic process is known as activation-induced cell death (AICD). The molecular basis for the differential susceptibility of Th1 and Th2 cells to AICD is not known. Here we show that the antiapoptotic variant, Tid-1 S , is selectively induced in murine Th2 cells following activation. Expression of a dominant-negative mutant of hTid-1 S in a Th2 cell line strikingly enhanced activation of caspase 3 in response to CD3 stimulation, and caused the cells to become sensitive to AICD. Hence, the accumulation of Tid-1 S in Th2 cells following activation represents a novel mechanism that may contribute to the induction of apoptosis resistance during the activation of Th2 cells.
Introduction
The human nuclear TID1 gene encodes alternatively spliced proteins, hTid-1 L and hTid-1 S , which are predominantly localized to the mitochondrial matrix (Syken et al., 1999) . These proteins, hereafter termed TidL and TidS, respectively, are homologues of the Drosophila tumor suppressor Tid56 (Kurzik-Dumke et al., 1992 . Loss of expression of Tid56 leads to the growth of lethal tumors in the imaginal discs of Drosophila larvae. Tid56, TidL and TidS are all members of the DnaJ family of molecular chaperones (Caplan et al., 1993; Cyr et al., 1994; Silver and Way, 1993) , which contain a conserved J domain and act as cochaperones and specificity factors for Hsp70 family proteins. DnaJ proteins have been implicated in cellular transformation and the SV40 large tumor antigen (TAg) contains an amino-terminal J-domain, which plays an important role in the transforming function of this viral oncoprotein (reviewed in Sullivan and Pipas, 2002) . The TID1-encoded protein was originally isolated in a yeast two-hybrid screen with the human papillomavirus E7 oncoprotein as a bait (Schilling et al., 1998) . Additional viral proteins reported to interact with Tid proteins include the HTLV-1 oncoprotein tax (Cheng et al., 2001) , and the herpes simplex virus type 1 UL9 protein (Eom and Lehman, 2002) . Ectopic Tid expression interferes with the transformed phenotype of tumor cell lines consistent with a tumor suppressor function of the human Tid proteins (Cheng et al., 2001) .
The human TidL and TidS proteins differ only in their carboxyl termini; the carboxyl terminal 33 amino acids of human TidL are encoded in a single exon that is spliced and replaced by an alternatively spliced exon encoding the final six amino acids of human TidS (Syken et al., 1999) . The murine homologues of these splice variants, in particular their respective carboxyl termini, are highly conserved (Trentin et al., 2001) ( Figure 1a ). Our previous experiments with TidL and TidS J-domain mutants suggested that these splice variants have distinct cellular targets. The high degree of sequence conservation of the TidL-and TidS-specific carboxyl termini further supports our model that these domains may contribute to this substrate specificity (Syken et al., 1999) . We analysed mouse brain tissue by immunoblot using the monoclonal antibody RS-13 specific for human Tid proteins (Syken et al., 1999) . This antibody specifically detects two proteins of 43 and 40 kDa that comigrate on SDS-PAGE with human TidL and human TidS, respectively (Figure 1b) . Hence, these two forms correspond to the major splice variants that have been published (Trentin et al., 2001) . Consistent with this report there was no evidence for the expression of a third splice variant (Trentin et al., 2001; Yin and Rozakis-Adcock, 2001 ), supporting the notion that this form represents a low abundance mRNA species, and that the encoded protein may be highly unstable (Trentin et al., 2001) . Analysis of increasing amounts of NIH 3T3 cell extracts by SDS-PAGE, followed by immunoblotting and quantitation using a digital imaging system, showed that the ratio of the signal for murine TidL and murine TidS remained constant (Figure 1c) , demonstrating that the human Tid-specific RS-13 monoclonal antibody (Syken et al., 1999) recognized the murine TidL and TidS splice variants with similar efficiencies.
We have previously reported that TidL and TidS have opposing effects on apoptosis: TidL enhances apoptosis in response to multiple stimuli, whereas TidS restrains apoptosis under the same conditions (Syken et al., 1999) . Thus, the relative abundance or activity of these proteins may determine the level of apoptosis or cell survival via their ability to amplify or dampen the signals that specify these two outcomes. The balance between cell growth and apoptosis is particularly critical in the immune response. In response to antigen stimulation, T cells not only express cytokines necessary for autocrine proliferation but also undergo an apoptotic process known as activation-induced cell death (AICD) (reviewed in Baumann et al., 2002) . This dual response averts the dangers of uncontrolled lymphocyte proliferation, while at the same time supporting a level of lymphocyte expansion that suffices for immune defense. Activated T cells upregulate the cell surface protein FasL that binds the death receptor Fas and activates its downstream caspases, thereby leading to cell death. Not only is AICD involved in the deletion of active T cells in order to terminate an immune response, it is also responsible for the deletion of self-reactive T cells during T-cell maturation in the thymus (reviewed in Green and Scott, 1994) .
Two major subtypes of T helper cells have been distinguished by their cytokine expression patterns and their susceptibility to AICD. Th1 cells, which characteristically produce IFN-g, are derived by culturing CD4 T cells with antigen in the presence of IL-12, while Th2 cells that characteristically produce IL-4, IL-5 and IL-13 are derived by culturing CD4 T cells with antigen in the presence of IL-4 (Swain et al., 1991; O'Garra and Murphy, 1994; Seder and Paul, 1994) . Upon activation, Th1 cell lines undergo AICD within 12-48 h, while Th2 cell lines are significantly more resistant (Varadhachary et al., 1997; Zhang et al., 1997; Carter et al., 1998) . The mechanism underlying resistance to AICD in Th2 cell lines is not clear, but is thought to involve inductive signaling through the CD3/TCR complex (Varadhachary et al., 1997) .
The different propensities of Th1 and Th2 cell lines to undergo AICD led us to examine whether the relative levels of Tid proteins change in response to activating signals. Although activation of helper T cells can cause cell death, activating signals generated by the TCR/CD3 complex also result in the production of survival signals in the context of a Th2 cell (Varadhachary et al., 1997) . These TCR/CD3-generated inductive signals may be at least partially responsible for Th2 cell resistance to AICD. To examine whether TCR/CD3 signals modulate the relative abundances of the pro-and antiapoptotic splice forms of Tid proteins we stimulated D5 Th1 and D10 Th2 cell lines with immobilized anti-CD3e antibodies. Activation with anti-CD3e caused a specific increase of the antiapoptotic TidS protein and altered the relative abundances of the two splice variants in D10 Th2 but not in D5 Th1 cells (Figure 2a) .
The D5 Th1 cells and the D10 Th2 cells are clonal lines that have been used extensively to study T-cell differentiation (Kaye et al., 1983; Rao et al., 1984; Agarwal and Rao, 1998) . We tested two additional Th1 cell lines and two additional Th2 cell lines for antiCD3e-mediated induction of murine TidS expression. Consistent with the results obtained with the D5 and D10 clones, the Th1 lines 7A5 and D1.1 exhibited no activation-induced upregulation of TidS. In contrast, treatment of the Th2 lines HAE 4A6 and CDC35 with anti-CD3e for 24 h resulted in the specific upregulation of TidS (Figure 2b ). . Cells were lysed in 1% NP40, 150 mm NaCl, 50 mm Tris-HCl, pH 8.0, and 1 mg/ml each of aprotinin and leupeptin, 0.01% PMSF for 30 min on ice. Samples were separated by SDS-PAGE, transferred to PVDF membranes and probed with the RS-13 anti-hTid-1 monoclonal antibody (Santa Cruz SC18819; Neomarkers TID-1AB-2); (Syken et al., 1999) . This antibody recognizes an epitope that is conserved between the short and long splice forms of the TID1 protein. Detection was by ECL (Amersham) and images were acquired digitally using a BioRad BioFluor Max S supercooled CCD camera setup. Membranes were routinely stripped and reprobed with an actin antibody (Sigma) to ensure equal loading. (c) The human Tid-specific RS-13 antibody (Santa Cruz SC18819; Neomarkers TID-1AB-2); (Syken et al., 1999) recognizes the murine splice variants with similar efficiency. Increasing amounts of total cell extracts prepared from murine NIH 3T3 fibroblasts were analysed. The ratio of the signals of the two splice variants remains constant
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To determine whether TidS upregulation also occurs in primary Th2 cells, we differentiated primary T cells towards a Th2 phenotype by a standard protocol (Agarwal and Rao, 1998) . We then activated these freshly polarized Th2 cells with immobilized anti-CD3e and determined the relative levels of TidS and TidL expression. Like the three different Th2 cell lines that we tested (Figure 2a, b) , these primary Th2 cultures showed an increase in TidS expression in response to CD3e ligation (Figure 2c) . Thus, the ratio of TidS to TidL protein levels is substantially altered in Th2 cells, but not in Th1 cells, upon activation (Figure 2) .
We have previously reported that human TidS downregulates apoptosis in the human osteosarcoma cell line U2OS (Syken et al., 1999) . To investigate whether TidS has a similar effect in T cells, Jurkat cells were transiently cotransfected with expression plasmids encoding human TidS and murine CD4, and productively transfected cells were isolated by selecting for murine CD4 expression. The level of human TidS expression in the transfected cells, determined by immunoblotting (Figure 3a) , was comparable to the amount of endogenous TidS in murine Th2 cell lines after activation (Figure 2) . The TidS-transfected Jurkat cells showed a significant (Bfourfold) decrease in apoptosis in response to Fas activation or mitomycin C treatment (Figure 3a) , demonstrating that TidS can also negatively modulate apoptosis in T cells.
Several studies have implicated Fas in signaling AICD (Ju et al., 1995) . The ability of TidS to inhibit Fasmediated apoptosis in Jurkat cells, and the correlation of TidS upregulation with resistance to AICD in Th2 cells, suggested that TidS in addition to other factors might play a role in modulating AICD. To test this hypothesis, we used the previously characterized H121Q TidS mutant (Syken et al., 1999) . This protein is mutated in a highly conserved histidyl residue in the Jdomain that is known to mediate interaction between (Rao et al., 1984) ; left) and D10 Th2 cells (D10.G4.1 (Kaye et al., 1983) ; right). All cells were cultured in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal calf serum, l-glutamine, penicillinstreptomycin, nonessential and essential amino acids, vitamins, HEPES, 2-mercaptoethanol, and 10 U/ml purified rat IL-2 (Collaborative Biomedical Products). D10 cells also contained 25 U/ml recombinant IL-4 (added as supernatant from the I3L6 cell line that was transfected with a constitutively expressed murine IL-4 cDNA). T-cell clones were restimulated with antigen and irradiated antigen-presenting cells every 4 weeks; cells were expanded and used for analysis only after 2 weeks of rest following restimulation. For primary T-cell analysis, spleen and lymph nodes were isolated from DO11.10 TCR transgenic mice (typically 4-6 weeks old) and CD4 þ cells were purified using magnetic beads (Dynal). Th2 differentiation was carried out as previously described (Agarwal and Rao, 1998). Differentiated T cells were analysed at 7-10 days after primary stimulation Expression of human TidS can negatively regulate apoptosis in the human T-cell line Jurkat. Cells were cultured in DMEM supplemented with 10% fetal calf serum, 10 mm HEPES, and 2 mm l-glutamine and transfected by electroporation in serum-free medium with pulses of 250 V and 960 mF. Typically, 5 Â 10 7 cells were transfected with 50 mg of empty pCMV (c) or pCMV-TidS and 50 mg of a murine CD4 expression plasmid. After 24 h, transfected cells were selected for CD4 expression with magnetic beads (Dynal) to enrich for cells coexpressing TidS as previously described (Aramburu et al., 1999) . Cells were treated with 60 mm mitomycin C (Sigma) for 24 h (MMC) (left panel), or 1 mg/ml agonistic Fas antibody (Clone # DX 2.1, R&D Systems) for 2 h (right panel). Apoptosis was measured using a quantitative DNA laddering assay (Cell Death Detection ELISA PLUS ; Roche). In this photometric enzyme immune assay, the amount of cytoplasmic histone-associated DNA fragments is determined. Cells (1 Â 10 5 ) were used for each assay, and each experiment was performed in triplicate or quadruplicate. The fold increase between treated and untreated populations was determined for each cell type, and values were normalized to allow direct comparison. The data are presented as the relative ratio of death observed in treated versus untreated populations. (b) The dominant-negative human TidS mutant H121Q S renders D10 Th2 cell resistant to AICD. D5 Th1 cells, untransfected D10 Th2 cells (U), as well as Th2 populations transfected with empty vector (C) or an H121Q S expression vector were treated with anti-CD3e antibody. Apoptosis was determined as described in (a)
Modulation of activation-induced cell death J Syken et al dnaJ and Hsp70 family proteins (Wall et al., 1994; Tsai and Douglas, 1996) . The H121Q TidS protein will efficiently interact with TidS-specific substrates but because of its lack of Hsp70 interaction cannot function as a chaperone and acts as a dominant-negative mutant (Syken et al., 1999) . We predicted that if TidS upregulation in activated Th2 cells contributes to AICD resistance, expression of dominant-negative TidS would functionally balance TidS induction, diminish this resistance, and hence render Th2 cells more sensitive to apoptosis following activation. D10 Th2 cells were stably transfected with either H121Q-TidS or vector control plasmids, and pools of G418-resistant cells were selected. These cells grew as well as untransfected cells, and did not exhibit increased levels of spontaneous apoptosis. The H121Q-TidS protein was expressed at levels similar to that reached by endogenous murine TidS after activation (Figure 3b ). After stimulation with anti-CD3e, D10 Th2 cells expressing the dominantnegative TidS showed significantly increased AICD relative to vector-transfected or untransfected D10 Th2 cells; the level of AICD was comparable to that of D5 Th1 cells that were activated in parallel (Figure 3b ). These results suggest that interfering with normal TidS function in D10 Th2 cells abrogates their resistance to AICD. Attempts to express TidS in D5 Th1 cells failed because of the low transfection efficiency of these cells and their predisposition to undergo cell death upon gene transduction. We used fluorogenic caspase activity assays to measure caspase-3 and caspase-8 activity in the D10 Th2 cells stably expressing H121Q TidS, as well as in vector-transfected D10 Th2 cells, untransfected D10 Th2 cells, and D5 Th1 cells 24 h after activation with anti-CD3e. Caspase-8 activity was similar in each of these cell populations, while caspase-3 activity was notably higher in D5 Th1 cells and in D10 Th2 cells expressing H121Q TidS, compared to untransfected or vector-transfected D10 Th2 cells (Figure 4 ). Since caspase activity in the H121Q-TidS-expressing D10 cells was even higher than in D5 Th1 cells, additional factors may contribute to the efficiency of pro-caspase-3 activation downstream of mitochondria in Th1 versus Th2 cells.
Although the molecular mechanism behind Th2 resistance to AICD is not known, several models have been proposed to explain this phenomenon. Fasassociated phosphatase-1 (FAP-1) is expressed at higher levels in Th2 than in Th1 cells. This may inhibit Fasmediated AICD signaling thus conferring resistance to AICD in this cell type (Zhang et al., 1997) . Less efficient pro-caspase-8 activation in Th2 cells has also been reported (Varadhachary et al., 1999) . This may be a consequence of FAP-1 or the caspase-8 inhibitory protein c-FLIP short (Van Parijs et al., 1999; Kirchhoff et al., 2000) . Based on the results presented here, we propose that the activation-induced accumulation of TidS in Th2 cells also contributes to their resistance to AICD.
We have previously demonstrated that in the human osteosarcoma cell line U2OS, TidL and TidS are predominantly mitochondrial matrix-associated proteins that can modulate mitochondrial aspects of apoptosis, including cytochrome c release and caspase-3 activation (Syken et al., 1999) . The major Tid protein pool is localized to the mitochondria before and after activation of Jurkat or D10 cells (data not shown) consistent with all other reports where Tid localization has been analysed (Syken et al., 1999; Cheng et al., 2001; Sarkar et al., 2001; Trentin et al., 2001) . Like in the osteosarcoma cell line U2OS, TidS affected activation of caspase 3 but not caspase 8 in Th2 cells, which would be consistent with the model that Tid proteins can affect mitochondrial aspects of apoptosis, even though no mitochondrial targets of Tid proteins have been identified yet. A mitochondrial function of Tid proteins appears at variance, however, with reports that have suggested that mitochondria do not play a major role in the regulation of AICD. In particular, bcl-2 family members, important regulators of mitochondrial aspects of apoptosis, are expressed at similar levels in Th1 and Th2 cells before and after activation, and do not markedly affect AICD (Strasser et al., 1995; Van Parijs et al., 1996; Zhang et al., 1997) . Hence it appears likely that TidS also affects AICD through nonmitochondrial mechanisms that impinge on caspase-3 activation. This is consistent with our finding that despite similar caspase-8 activity, caspase-3 activity in the H121Q-TidS-expressing D10 cells is higher than in D5 Th1 cells (Figure 4 ). Recent reports have provided evidence for the existence of nonmitochondrial pools of Tid proteins (Cheng et al., 2001; Sarkar et al., 2001; Trentin et al., 2001; K Edwards and K Mu¨nger, unpublished) , and human Tid protein was originally cloned as a cellular target of the predominantly nuclear human papillomavirus E7 oncoprotein (Schilling et al., 1998) . Tid proteins have also reported to interact with other nonmitochondrial viral proteins, including HTLV-1 tax that induces marked cytoplasmic relocalization of Tid (Cheng et al., 2001) . In addition to mitochondrial hsp70 (Syken et al., 1999) Tid proteins can also interact with cytoplasmic hsc70 (Sarkar et al., 2001; Trentin et al., 2001) , and several nonmitochondrial cellular target proteins of the Tid/hsc70 complex have been identified. Murine Tid proteins can interact with the p120 GTPase activating protein (GAP), which downregulates ras by enhancing its GTPase activity (Trentin ). In EGF-stimulated NIH 3T3 cells GAP colocalized with Tid proteins to the mitochondria, suggesting that these proteins may modulate ras activity through compartmentalization of GAP (Trentin et al., 2001) . Additional studies will be necessary to determine whether a similar colocalization of GAP may also occur upon stimulation of T helper cells. It may be speculated that because of the increased levels of TidS in activated Th2 cells, GAP may be more effectively tethered to the mitochondria possibly resulting in higher ras activity in these cells, which may impact survival during activation. Tid proteins can also modulate IFN-g signaling by interacting with the protein tyrosine kinase Jak2 and the IFN-g receptor subunit IFN-gR2 (Sarkar et al., 2001) . Jak2 plays an important role in multiple cytokine signal transduction pathways and Tid was shown to modulate IFN-g-mediated transcriptional activation (Sarkar et al., 2001) . Interestingly, T cells of IFN-g receptor-deficient mice are hyperproliferative and show increased resistance to AICD (Lohman and Welsh, 1998) . Moreover, IFN-g can modulate expression of FasL through a direct transcriptional mechanism and it is thus possible that by interfering with IFN-g signaling, Tid may interfere with FasL synthesis and thus inhibit AICD. One prediction of this model is that activity of the receptor proximal caspase 8 would be inhibited and this inhibition would be abrogated in H121Q-TidS expressing Th2 cells. Our results, however, provide no evidence for the modulation of caspase-8 activity in these cells (Figure 4 ). The recent finding that Tid proteins can modulate NF-kB signaling by repressing the IkB kinase b subunit and can thereby interfere with IkBa phosphorylation and nuclear translocation of NF-kB may also be of importance to our results. The NF-kB transcription factor is an important modulator of apoptosis, including CD95/Fas-mediated apoptosis, which mediates AICD (reviewed in Barkett and Gilmore, 1999; Li-Weber and Krammer, 2002) . Vitamin E or the anti-inflammatory compound parthenolide that interfere with NF-kB activation inhibits AICD presumably by suppressing FasL synthesis at the transcriptional level (Li-Weber et al., 2002a, b) . Our results, again, do not support such a mechanism for Tid action since caspase-8 activation in a Th2 cell line expressing the dominant-negative H121Q-TidS mutant is not markedly affected (Figure 4) .
Of interest is also hRFI that was identified as a human TidL interacting protein in a yeast two-hybrid screen (Sasaki et al., 2002) . The hRFI protein contains a ring finger with homology to X-linked inhibitor of apoptosis (XIAP). It is overexpressed in 70% of primary esophageal tumors and maps to chromosome 12q23-24.1 a region that is mutated in some cancers. Ectopic hRFI expression can interfere with TNFinduced apoptosis of HeLa cells, and hRFI can be cleaved by caspase 3. Importantly, however, hRFI lacks the BIR domain that is necessary for apoptosis inhibition, and is conserved in all other IAPs (Sasaki et al., 2002) . Regardless, given its antiapoptotic activity and the overexpression in primary human tumors, hRFI is an attractive target for TidL and it will be interesting to determine whether hRFI can also interact with TidS.
The promoter sequence of the human TID1 gene has been analysed and shown to contain consensus-binding sites for multiple transcription factors implicated in cell growth and survival responses, such as AP-1, PEA3, E2F, and NF-kB ). Nevertheless, this is the first report that TID1 protein levels are modulated in response to a cellular survival signal suggesting that these tumor suppressor homologues may act as physiological regulators of cell death. The specific increase of TidS levels during the activation of Th2 cells may be regulated at the level of splicing or may be the consequence of specific stabilization/ destabilization of TidS and TidL proteins or mRNAs, respectively. All of our results suggest that, consistent with our previous work, (Syken et al., 1999) Tid proteins affect AICD in Th2 cells at the level of caspase-3 activation whereas the activity of the receptor-proximal caspase is not affected.
